证券记录 · 已归档季度
CNTA
Centessa Pharmaceuticals plc · Healthcare · Biotechnology
17被追踪持有人
0Δ持有人
26.76M持有股份
$648.81M报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +2.4% · 净新建仓位 0.0% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q1 2026 | 55 | +3 | 43.68M | $1.73B | +11 | −8 |
| Q4 2025 | 52 | -1 | 46.49M | $1.16B | n/a | −1 |
| Q3 2025 | 17 | 0 | 26.76M | $648.81M | +1 | −1 |
| Q2 2025 | 14 | +1 | 24.28M | $319.09M | +2 | −1 |
| Q1 2025 | 11 | 0 | 16.47M | $236.89M | n/a | n/a |
| Q4 2024 | 11 | -1 | 15.51M | $259.80M | n/a | −1 |
| Q3 2024 | 11 | +2 | 13.11M | $209.59M | +2 | n/a |
| Q2 2024 | 9 | n/a | 8.99M | $81.17M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 10.04M | +19.4% | $243.35M | 0.4% | ▲ Add | 6 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 6.28M | +64.1% | $152.22M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | T. Rowe Price ✦ | 4.80M | -18.7% | $116.50M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 4 | Morgan Stanley ✦ | 1.12M | n/a | $27.27M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 5 | Point72 Asset Management ✦ | 1.07M | -58.6% | $26.01M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 6 | Millennium Management ✦ | 902.27K | -45.6% | $21.88M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 7 | Capital World Investors ✦ | 684.80K | +64.3% | $16.61M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | JPMorgan Chase ✦ | 483.79K | n/a | $11.73M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 9 | BlackRock ✦ (被动) | 408.39K | +7.2% | $9.90M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 10 | Goldman Sachs Group ✦ | 247.56K | n/a | $6.00M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 164.60K | -57.2% | $3.99M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 137.20K | 新增 | $3.33M | 0.0% | New | 1 | SEC ↗ |
| 13 | Marshall Wace ✦ | 113.59K | -66.9% | $2.75M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 14 | Geode Capital Management ✦ (被动) | 95.03K | +8.7% | $2.30M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | Wellington Management ✦ | 82.67K | -44.7% | $2.00M | 0.0% | ▼ Trim | 5 | SEC ↗ ×3 |
| 16 | D. E. Shaw & Co. ✦ | 64.39K | +308.5% | $1.56M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 57.44K | -20.4% | $1.39M | 0.0% | ▼ Trim | 6 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Citadel Advisors | $3.33M | 0.0% |
已清仓
| State Street Global Advisors | $603,284 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 159 持有人, 148.16M 股份, $5.86B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据